Jeffrey B Kindler Precigen, Inc. (PGEN) insider trading activity

Jeffrey B Kindler is Director of PRECIGEN, INC.. Currently has a direct ownership of 520,430 shares of PGEN, which is worth approximately $827,483. The most recent transaction as insider was on Mar 14, 2025, when has been sold 87,412 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 520K

32.3% 3M change

32.3% 12M change

Total Value Held $827,483

JEFFREY B KINDLER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 14 2025	BUY Exercise of conversion of derivative security	-	87,412 Added 14.38%	520,430 Common Stock
Mar 13 2025	BUY Grant, award, or other acquisition	$68,999 $1.74 p/Share	39,655 Added 8.39%	433,018 Common Stock
Mar 14 2024	BUY Grant, award, or other acquisition	$68,998 $1.43 p/Share	48,251 Added 10.93%	393,363 Common Stock
Mar 09 2024	BUY Exercise of conversion of derivative security	-	106,837 Added 23.64%	345,112 Common Stock
Dec 28 2023	SELL Open market or private sale	$136,327 $1.41 p/Share	96,686 Reduced 28.86%	238,275 Common Stock
Mar 09 2023	BUY Grant, award, or other acquisition	$68,999 $1.17 p/Share	58,974 Added 14.97%	334,961 Common Stock
Feb 22 2023	BUY Exercise of conversion of derivative security	-	61,576 Added 18.24%	275,987 Common Stock
Aug 11 2022	SELL Open market or private sale	$115,000 $2.3 p/Share	50,000 Reduced 18.91%	214,411 Common Stock
Mar 25 2022	BUY Exercise of conversion of derivative security	-	16,212 Added 5.78%	264,411 Common Stock
Feb 22 2022	BUY Grant, award, or other acquisition	$69,000 $2.03 p/Share	33,990 Added 12.05%	248,199 Common Stock
Mar 25 2021	BUY Grant, award, or other acquisition	$68,997 $7.71 p/Share	8,949 Added 4.01%	214,209 Common Stock
Mar 13 2021	BUY Exercise of conversion of derivative security	-	62,189 Added 23.25%	205,260 Common Stock

Also insider at

PPD

PPD, Inc. Healthcare

Director

PRGO

PERRIGO Co plc Healthcare

Director

TERN

Terns Pharmaceuticals, Inc. Healthcare

JBK